Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Patrick C. O'Brien, JD, PHARMD

Patrick C. O'Brien, JD, PHARMD

General Counsel

Arrowhead Research Corporation, United States

Learning Objective : Describe how to implement compliance controls into our industry; Discuss how the Office of Inspector General lays out requirements that effects corporate integrity agreements.`

Speaker(s)

Patrick C. O'Brien, JD, PHARMD

The Science of Compliance

Patrick C. O'Brien, JD, PHARMD

Arrowhead Research Corporation, United States

General Counsel

Francesca  Gino, PHD

Panelist

Francesca Gino, PHD

Harvard University Business School, United States

Associate Professor, Negotiation, Organization, and Markets Unit

Mary Patrice  Brown, JD

Panelist

Mary Patrice Brown, JD

O'Melveny & Myers LLP, United States

Partner, White Collar Defense and Corporate Investigations Practice

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.